The effect of LB-100 treatment sensitizes pancreatic cancer cells to radiation by activating CDC25C/CDK1 and inhibiting the homologous recombination repair (HRR) pathways, suggesting that LB-100 can activate cell cycle progression and stall DNA damage repair mechanisms in cancer cells through inducing PP2A inhibition [120]. The gene discussed is PTPA; the disease is cancer.